Notas de prensa

MingMed Biotechnology Presents Positive Phase II Data of Oral QA102 for the Treatment of Intermediate Age-Related Macular Degeneration (AMD) at Association for Research in Vision and Ophthalmology (ARVO) 2026

MingMed Biotechnology presenta datos positivos de QA102 oral para la degeneración macular asociada a la edad

Vernal Capital Acquisition Corp. anuncia el precio de su oferta pública inicial de 100 millones de dólares

VERNAL CAPITAL ACQUISITION CORP. ANUNCIA EL PRECIO DE SU OFERTA PÚBLICA INICIAL POR VALOR DE 100 MILLONES DE DÓLARES

VERNAL CAPITAL ACQUISITION CORP. ANNOUNCES PRICING OF $100 MILLION INITIAL PUBLIC OFFERING

eBay Launches Authenticity Guarantee for Trading Cards in the UK

Missy Sue Mastel Launches Climate Impact Accelerator Program

Ultima Markets celebra su décimo aniversario

Ultima Markets Celebrates 10th Anniversary

Ultima Markets celebra su décimo aniversario